Serial 88581512
Live / Registered — Registered (as of 24 Aug 2021)
What this means for you
Registered since 24 Aug 2021. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88581512
- Registration number
- 6465403
- Mark type
- Design / logo
- Filed
- 16 Aug 2019
- Registered
- 24 Aug 2021
- Attorney of record
- Laila Wolfgram
Goods and services
- Class 005 — Pharmaceuticals: Biological tissue in the nature of umbilical cord, afterbirth and amniotic membrane tissue for use in oral surgery, namely, umbilical cord tissue, afterbirth tissue and amniotic membrane by itself, or separated into either of its component parts, amnion and chorion, and any part of the foregoing tissues in combination with either a natural or synthetic biodegradable polymer for use in perioplastic surgery, mucogingival surgery, reconstruction of the oral mucosa and/or other related soft tissue regeneration procedures, guided tissue regeneration, guided bone regenerations, or other procedures related to new bone formation in the mandible and maxilla; Human allograft tissue
Owner
- COMMUNITY BLOOD CENTER, DBA SOLVITA, DAYTON, OH, US
- SNOASIS MEDICAL LLC, DENVER, CO, US
- SNOASIS MEDICAL LLC, DENVER, CO, US
- Snoasis Medical, Inc., Denver, CO, US
Prosecution history
- 20 Nov 2024 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 24 Aug 2021 — REGISTERED-SUPPLEMENTAL REGISTER
- 16 Jul 2021 — LAW OFFICE PUBLICATION REVIEW COMPLETED
- 08 Jul 2021 — APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
- 08 Jul 2021 — EXAMINER'S AMENDMENT ENTERED
- 08 Jul 2021 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 08 Jul 2021 — EXAMINERS AMENDMENT E-MAILED
- 08 Jul 2021 — EXAMINERS AMENDMENT -WRITTEN
- 16 Jun 2021 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 12 Jun 2021 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Jun 2021 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Jun 2021 — TEAS REQUEST FOR RECONSIDERATION RECEIVED
- 06 Mar 2021 — NOTIFICATION OF FINAL REFUSAL EMAILED
- 06 Mar 2021 — FINAL REFUSAL E-MAILED
- 06 Mar 2021 — FINAL REFUSAL WRITTEN